4925 — HABA LABORATORIES Balance Sheet
0.000.00%
- ¥6bn
- ¥3bn
- ¥12bn
- 79
- 90
- 23
- 75
Annual balance sheet for HABA LABORATORIES, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 5,664 | 5,651 | 4,818 | 3,959 | 4,744 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,200 | 1,126 | 975 | 1,258 | 1,196 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 11,314 | 10,072 | 9,344 | 9,077 | 9,035 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5,003 | 4,655 | 4,452 | 2,956 | 2,970 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 17,441 | 15,685 | 14,655 | 12,431 | 12,344 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,453 | 2,532 | 2,798 | 2,814 | 2,659 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5,402 | 4,048 | 3,882 | 3,924 | 3,417 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 12,039 | 11,638 | 10,774 | 8,507 | 8,927 |
| Total Liabilities & Shareholders' Equity | 17,441 | 15,685 | 14,655 | 12,431 | 12,344 |
| Total Common Shares Outstanding |